KINLECTA



Trademark Coverage

No Class Specified

Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, inflammation, infections, gastrointestinal diseases and disorders, and nervous system diseases and disorders

Owner

AstraZeneca AB

Business in Södertälje SE-151 85, SE

Owns 915 trademarks

Timeline
  • Feb 03
    2014
    Abandonment Notice Mailed No Use Statement Filed
  • Feb 03
    2014
    Abandonment No Use Statement Filed
  • Jul 02
    2013
    NOA E Mailed SOU Required From Applicant
  • May 07
    2013
    Official Gazette Publication Confirmation E Mailed
  • May 07
    2013
    Published For Opposition
  • Apr 17
    2013
    Notification Of Notice Of Publication E Mailed
  • Apr 01
    2013
    Law Office Publication Review Completed
  • Mar 31
    2013
    Approved For PUB Principal Register
  • Mar 29
    2013
    Examiner's Amendment Entered
  • Mar 29
    2013
    Notification Of Examiners Amendment E Mailed
  • Mar 29
    2013
    Examiners Amendment E Mailed
  • Mar 29
    2013
    Examiners Amendment Written
  • Oct 18
    2012
    Notification Of Final Refusal Emailed
  • Oct 18
    2012
    Final Refusal E Mailed
  • Oct 18
    2012
    Final Refusal Written
  • Oct 15
    2012
    TEAS/Email Correspondence Entered
  • Oct 15
    2012
    Correspondence Received In Law Office
  • Oct 02
    2012
    Assigned To LIE
  • Sep 24
    2012
    TEAS Response To Office Action Received
  • Jul 09
    2012
    Attorney Revoked And/Or Appointed
  • Jul 09
    2012
    TEAS Revoke/Appoint Attorney Received
  • Mar 28
    2012
    Notification Of Non Final Action E Mailed
  • Mar 28
    2012
    Non Final Action E Mailed
  • Mar 28
    2012
    Non Final Action Written
  • Mar 27
    2012
    Assigned To Examiner
  • Jan 03
    2012
    New Application Office Supplied Data Entered In TRAM
  • Dec 24
    2011
    New Application Entered In TRAM